Largest companies in Switzerland
The 26 companies domiciled in Switzerland that trade on a US exchange, ranked by market capitalisation. Domicile comes from each company's own SEC filing, so a company headquartered here but listed only on its home market does not appear.
Combined market cap
$922.182 B
1.0% of all US-listed value
Companies
26
Ranked #8 of 55 countries
Average
$35.469 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1 | NovartisNVS | $309.0B | $161.93 | -1.85% | Switzerland |
| 2 | UBS GroupUBS | $151.1B | $48.68 | -3.94% | Switzerland |
| 3 | ChubbCB | $142.2B | $372.09 | -0.56% | Switzerland |
| 4 | Johnson Controls InternationalJCI | $79.6B | $131.44 | -6.47% | Switzerland |
| 5 | GarminGRMN | $55.3B | $286.75 | -0.83% | Switzerland |
| 6 | AlconALC | $38.3B | $76.69 | -0.80% | Switzerland |
| 7 | STMicroelectronicsSTM | $35.5B | $39.76 | -12.81% | Switzerland |
| 8 | Mettler Toledo InternationalMTD | $33.6B | $1,675.49 | -2.77% | Switzerland |
| 9 | AmrizeAMRZ | $22.7B | $42.61 | -3.50% | Switzerland |
| 10 | OnONON | $22.6B | $37.41 | -3.13% | Switzerland |
| 11 | PENTAIRPNR | $11.2B | $69.84 | -3.04% | Switzerland |
| 12 | TransoceanRIG | $5.70B | $5.11 | -6.33% | Switzerland |
| 13 | CRISPR TherapeuticsCRSP | $4.71B | $48.58 | -6.17% | Switzerland |
| 14 | Sportradar GroupSRAD | $4.42B | $14.17 | -2.21% | Switzerland |
| 15 | Garrett MotionGTX | $3.57B | $19.37 | -2.05% | Switzerland |
| 16 | Aebi SchmidtAEBI | $858.2M | $11.06 | -4.90% | Switzerland |
| 17 | Sophia GeneticsSOPH | $570.4M | $6.70 | -3.87% | Switzerland |
| 18 | OculisOCS | $419.1M | $6.81 | -6.53% | Switzerland |
| 19 | SEALSQLAES | $273.5M | $1.23 | -14.15% | Switzerland |
| 20 | AC ImmuneACIU | $212.7M | $2.09 | -8.73% | Switzerland |
| 21 | ADC TherapeuticsADCT | $207.5M | $1.63 | -5.52% | Switzerland |
| 22 | Veraxa Biotech AG - Post de-SPACVRXA | $139.4M | $0.99 | +3.80% | Switzerland |
| 23 | Molecular PartnersMOLN | $120.6M | $3.22 | -1.98% | Switzerland |
| 24 | WISeQeyWQEY | $78.3M | $6.53 | -3.90% | Switzerland |
| 25 | NewcelXNCEL | $16.4M | $2.84 | +12.25% | Switzerland |
| 26 | Addex TherapeuticsADXN | $4.86M | $2.85 | -4.04% | Switzerland |
All 26 companies. One row per company, with secondary share classes folded into their primary listing.
Other countries
🇺🇸 United States 4,017🇨🇦 Canada 244🇬🇧 United Kingdom 74🇹🇼 Taiwan 23🇳🇱 Netherlands 25🇯🇵 Japan 27🇰🇷 South Korea 13🇮🇪 Ireland 23🇨🇳 China 249🇧🇷 Brazil 28🇩🇪 Germany 14🇦🇺 Australia 30🇫🇷 France 16🇲🇽 Mexico 16🇮🇳 India 9🇪🇸 Spain 5🇱🇺 Luxembourg 16🇩🇰 Denmark 7🇮🇹 Italy 5🇮🇱 Israel 117🇧🇲 Bermuda 36🇧🇪 Belgium 7🇰🇾 Cayman Islands 29🇦🇷 Argentina 14All countries →
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.